Wimbledon Neurocare Limited - Limited company - abbreviated - 11.0.0

Wimbledon Neurocare Limited - Limited company - abbreviated - 11.0.0


07487836 1.1.13 31.12.13 31.12.13 Company accounts Private Limited Company FY true false true false true false false Ordinary Shares 1.00000 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure074878362012-12-31074878362013-12-31074878362013-01-012013-12-31074878362011-12-31074878362012-01-012012-12-31074878362012-12-3107487836ns12:England2013-01-012013-12-3107487836ns14:PoundSterling2013-01-012013-12-3107487836ns7:Director12013-01-012013-12-3107487836ns7:Director22013-01-012013-12-3107487836ns7:OrdinaryShareClass12013-01-012013-12-3107487836ns7:CompanySecretary2013-01-012013-12-3107487836ns7:RegisteredOffice2013-01-012013-12-3107487836ns7:EntityAccountantsOrAuditors2013-01-012013-12-3107487836ns5:PlantMachinery2013-01-012013-12-3107487836ns7:OrdinaryShareClass12013-12-3107487836ns7:OrdinaryShareClass12012-12-31
REGISTERED NUMBER: 07487836 (England and Wales)













WIMBLEDON NEUROCARE LIMITED

ABBREVIATED UNAUDITED ACCOUNTS

FOR THE YEAR ENDED 31ST DECEMBER 2013






WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

CONTENTS OF THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31ST DECEMBER 2013










Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

WIMBLEDON NEUROCARE LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31ST DECEMBER 2013







DIRECTORS: Dr A Y M J Al-Memar
Dr O J F Foster





SECRETARY: Mrs A Amanuel





REGISTERED OFFICE: Unit 1 College Fields
16 Prince George Road
London
London
SW19 2PT





REGISTERED NUMBER: 07487836 (England and Wales)





ACCOUNTANTS: Sinclairs Bartrum Lerner
Chartered Accountants
39A Welbeck Street
London
W1G 8DH

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

ABBREVIATED BALANCE SHEET
31ST DECEMBER 2013

2013 2012
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 381,162 295,720

CURRENT ASSETS
Debtors 3 172,683 117,827
Cash at bank 216,918 265,978
389,601 383,805
CREDITORS
Amounts falling due within one year 80,578 174,976
NET CURRENT ASSETS 309,023 208,829
TOTAL ASSETS LESS CURRENT
LIABILITIES

690,185

504,549

PROVISIONS FOR LIABILITIES 47,396 8,475
NET ASSETS 642,789 496,074

CAPITAL AND RESERVES
Called up share capital 4 498,760 466,000
Share premium 163,800 -
Profit and loss account (19,771 ) 30,074
SHAREHOLDERS' FUNDS 642,789 496,074

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st December 2013.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st December 2013 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies
Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections
394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

ABBREVIATED BALANCE SHEET - continued
31ST DECEMBER 2013


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 4th July 2014 and were signed on its behalf by:




Dr A Y M J Al-Memar - Director



Dr O J F Foster - Director


WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE ABBREVIATED ACCOUNTS
FOR THE YEAR ENDED 31ST DECEMBER 2013


1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective April 2008).

Turnover
Turnover comprises revenue recognised by the company in respect of goods and services supplied during the
year, exclusive of Value Added Tax and trade discounts.

Services provided to patients are recognised as turnover according to the date when the treatments are provided.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Plant and machinery etc - 20% straight line on cost and 15% on cost

Deferred tax
Full provision is made for deferred tax assets and liabilities arising from all timing differences between the
recognition of gains and losses in the financial statements and recognition in the tax computation.

A net deferred tax asset is recognised only if it can be regarded as more likely than not that there will be suitable
taxable profits from which the future reversal of the underlying timing differences can be deducted.

Deferred tax assets and liabilities are calculated at the tax rates expected to be effective at the time the timing
differences are expected to reverse.

Deferred tax assets and liabilities are not discounted.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1st January 2013 372,845
Additions 177,851
At 31st December 2013 550,696
DEPRECIATION
At 1st January 2013 77,125
Charge for year 92,409
At 31st December 2013 169,534
NET BOOK VALUE
At 31st December 2013 381,162
At 31st December 2012 295,720

3. DEBTORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE
YEAR

The aggregate total of debtors falling due after more than one year is £ 7,000 (2012 - £ 7,000 )

WIMBLEDON NEUROCARE LIMITED (REGISTERED NUMBER: 07487836)

NOTES TO THE ABBREVIATED ACCOUNTS - continued
FOR THE YEAR ENDED 31ST DECEMBER 2013


4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 2013 2012
value: £    £   
498,760 Ordinary Shares £1 498,760 466,000

32,760 Ordinary Shares shares of £1 each were allotted as fully paid at a premium of £5 per share during the
year.

5. CONTROL NOTE

The company is under the control of no individual party.